Adult Attention Deficit Disorder

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

BrainsWay
BrainsWayJerusalem, Israel
1 program
1
Transcranial Direct Current StimulationPhase 11 trial
Active Trials
NCT02206516UnknownEst. Sep 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BrainsWayTranscranial Direct Current Stimulation

Clinical Trials (1)

NCT02206516BrainsWayTranscranial Direct Current Stimulation

Feasibility of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention Deficit Disorder (ADD).

Start: Jul 2014Est. completion: Sep 2018
Phase 1Unknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space